149489-17-8

Basic information

• Product Name: 2-(3-isopropoxyphenyl)ethanamine(SALTDATA: HCl)
• Synonyms: 2-(3-isopropoxyphenyl)ethanamine(SALTDATA: HCl);2-(3-isopropoxyphenyl)ethanamine;2-(3-isopropoxyphenyl)ethylamine
• CAS NO: 149489-17-8
• Molecular Formula: C₁₁H₁₇NO
• Molecular Weight: 179.25878
• Mol File: 149489-17-8.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(3-isopropoxyphenyl)ethanamine(SALTDATA: HCl)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-isopropoxyphenyl)ethanamine(SALTDATA: HCl)(149489-17-8)
• EPA Substance Registry System: 2-(3-isopropoxyphenyl)ethanamine(SALTDATA: HCl)(149489-17-8)

Safety Data

• Hazardous Substances Data: 149489-17-8(Hazardous Substances Data)

Usage

Salt form

Treated with hydrochloric acid (HCl) to increase stability and potentially alter properties.

Applications

Possible uses in pharmaceuticals, research, or as a reagent in chemical synthesis, depending on the intended application and conditions of use.

Upstream product

• 75792-33-5 3-isopropoxybenzaldehyde 

Downstream Products

• 149488-33-5 1-[2-(3-Isopropoxy-phenyl)-ethyl]-3-thiazol-2-yl-thiourea 

Relevant articles and documents

Method for inhibition of HIV related viruses

Treatment of AIDS, inhibition of the replication of HIV and related viruses thereof, and formulations using thiourea derivative compounds or salts thereof is disclosed. Also disclosed are novel thiourea derivative compounds.

Process for the preparation of (8As,12AS,13AS)-decahydroisoquino ((2,1-G) (1,6)-naphthyridin-8-one derivatives

The invention provides a process for preparing single enantiomers of compounds represented by the formula: STR1 and chiral acid addition salts thereof; wherein: X and Y are independently hydrogen; lower alkyl; lower alkoxy; or halo; or X and Y taken together is methylenedioxy or ethylene-1,2-dioxy; which includes reduction of a compound represented by the formula: STR2 to give a mixture of stereoisomers represented by the formula: STR3 wherein each wavy line independently represents a bond in either the α or β position; followed by dissolving the mixture of stereoisomers and a chiral resolving acid in a suitable solvent and allowing the solution to crystallize, giving a salt of the desired enantiomer.